Laboratory Evaluation of a SARS-CoV-2 RT-LAMP Test.

COVID-19 LMICs RT-LAMP RT-PCR molecular diagnostic performance

Journal

Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042

Informations de publication

Date de publication:
13 Jun 2023
Historique:
received: 21 03 2023
revised: 30 05 2023
accepted: 08 06 2023
medline: 27 6 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: epublish

Résumé

There is a need to have more accessible molecular diagnostic tests for the diagnosis of severe acute respiratory syndrome coronavirus 2 disease in low- and middle-income countries. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) may provide an attractive option as this technology does not require a complex infrastructure. In this study, the diagnostic performance of a SARS-CoV-2 RT-LAMP was evaluated using RT-PCR-confirmed clinical specimens of COVID-19-positive (n = 55) and -negative patients (n = 55) from the Netherlands. The observed sensitivity of the RT-LAMP test was 97.2% (95% CI: 82.4-98.0%) and the specificity was 100% (95% CI: 93.5-100%). The positive predictive value of the RT-LAMP was 100%, the negative predictive value 93.2% (95% CI: 84.3-97.3%), and the diagnostic accuracy was 96.4% (95% CI: 91.0-99.0%). The agreement between the RT-LAMP and the RT-PCR was "almost perfect" (κ-value: 0.92). The evaluated RT-LAMP might provide an attractive alternative molecular diagnostic tool for SARS-CoV-2 in resource limited settings.

Identifiants

pubmed: 37368738
pii: tropicalmed8060320
doi: 10.3390/tropicalmed8060320
pmc: PMC10302189
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Developping Countries Clinical Trials Partnership
ID : RIA2020EF-3012

Références

JAMA. 2020 Apr 28;323(16):1549-1550
pubmed: 32176764
Biosensors (Basel). 2022 Nov 27;12(12):
pubmed: 36551050
Microbiol Spectr. 2022 Dec 21;10(6):e0201222
pubmed: 36448777
Infection. 2023 Jan 2;:
pubmed: 36592297
Front Microbiol. 2022 Dec 22;13:1063414
pubmed: 36620063
MethodsX. 2023;10:102011
pubmed: 36643803
Life (Basel). 2022 Nov 21;12(11):
pubmed: 36431077
BMJ Open. 2016 Nov 14;6(11):e012799
pubmed: 28137831
J Infect Chemother. 2021 Feb;27(2):410-412
pubmed: 33214073
Viruses. 2022 Nov 25;14(12):
pubmed: 36560632
Analyst. 2021 Mar 7;146(5):1514-1528
pubmed: 33595550
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
PLoS One. 2023 Jan 26;18(1):e0279681
pubmed: 36701313
Nat Rev Microbiol. 2006 Sep;4(9 Suppl):S21-31
pubmed: 17034069
J Clin Virol. 2021 Jun;139:104821
pubmed: 33882373
PLoS One. 2023 Jan 25;18(1):e0277657
pubmed: 36696882
J Clin Virol Plus. 2023 Feb;3(1):100138
pubmed: 36683610
Expert Rev Mol Diagn. 2023 Jan;23(1):9-28
pubmed: 36695788
EBioMedicine. 2018 Nov;37:453-460
pubmed: 30396855
Int J Mol Sci. 2022 Oct 28;23(21):
pubmed: 36361893
Egypt J Immunol. 2023 Jan;30(1):14-19
pubmed: 36588449

Auteurs

Sandra Menting (S)

Amsterdam University Medical Centres, Academic Medical Centre at the University of Amsterdam, Laboratory for Experimental Parasitology, Department of Clinical Microbiology and Infection Prevention, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Annette Erhart (A)

MRC Unit The Gambia at the LSHTM, Atlantic Boulevard, Fajara, Banjul P.O. Box 273, The Gambia.

Henk D F H Schallig (HDFH)

Amsterdam University Medical Centres, Academic Medical Centre at the University of Amsterdam, Laboratory for Experimental Parasitology, Department of Clinical Microbiology and Infection Prevention, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Classifications MeSH